About Robert Butchofsky
Robert Butchofsky is a chief executive officer and director at Mati Therapeutics.
Robert Butchofsky reports to the SEC as a director or officer of 1 public company: Novelion Therapeutics (NVLNF).
Robert Butchofsky first appears on SEC filings in 2006.
Experience
This experience comes from Robert Butchofsky's profile and from SEC filings. For roles taken from filings, the years are when the filings name Robert Butchofsky in the role, so the role may have started earlier or lasted longer.
Mati Therapeutics Inc. Current
Founder and CEO (2012 – Present)
Director
2012 – Present · Austin, TX
Develops a device that delivers medication to people with eye diseases.
KA
KIPP Texas Public Schools - Austin
Board Member
2018 – 2022
SS
Superna Life Sciences
Chairman of the Board
2009 – 2016
CV
CDRD Ventures
Chairman of the Board
2013 – 2015
NI
Novelion Therapeutics Inc.
President and CEO, director
2006 – 2012 · Public company (NVLNF)
QI
QLT Inc.
President and CEO
1998 – 2012
AL
Allergan
Director of Botox Marketing
1990 – 1998
Key Colleagues at Startups
The people Robert Butchofsky works with at each company, as listed on that company's latest Form D.
Mati Therapeutics Inc. · Form D/A, Jul 2, 2026
LL
Linda Lupini
Director
JM
Jim Mazzo
Director
KJ
Ken Jones
Director
DF
Dave Fellows
Director
Cameron Nelson
Chief Financial Officer
PM
Peter McDonnell
Director
Christopher Muller
Chief Operating Officer and director
JI
Joseph Tortorice III
Director